Metrogel and Lantus drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Metrogel (metronidazole) and Lantus (insulin glargine recombinant). Common drug interactions include mental disorder among females and fatigue among males.

The phase IV clinical study analyzes what interactions people have when they take Metrogel and Lantus. It is created by eHealthMe based on reports of 40 people who take the same drugs from the FDA, and is updated regularly.

What is Metrogel?

Metrogel has active ingredients of metronidazole. It is often used in rosacea. eHealthMe is studying from 2,819 Metrogel users. Check the latest studies of Metrogel.

What is Lantus?

Lantus has active ingredients of insulin glargine recombinant. It is often used in diabetes. eHealthMe is studying from 191,782 Lantus users. Check the latest studies of Lantus.

On Jul, 20, 2026

40 people who take Metrogel and Lantus together, and have interactions are studied.

What are the common drug interactions of Metrogel and Lantus, by gender? *:

female:

Mental disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability)
Multiple injuries
Nephrogenic anaemia (anaemia due to kidney disease)
Nervous system disorder (a general class of medical conditions affecting the nervous system)
Osteoarthritis (a joint disease caused by cartilage loss in a joint)
Osteopenia (a condition where bone mineral density is lower than normal)
Osteoporosis (bones weak and more likely to break)
Parkinson's disease
Polymyalgia rheumatica (pain in many muscles)
Rectal haemorrhage (bleeding from anus)

male:

Fatigue (feeling of tiredness)
Abdominal pain
Dry mouth
Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters)
Epistaxis (bleed from the nose)
Eye disorder
Glycosylated haemoglobin increased
Haemoglobin decreased
Insomnia (sleeplessness)
International normalised ratio increased

What are the common drug interactions of Metrogel and Lantus, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Chronic kidney disease
Hyperkalaemia (damage to or disease of the kidney)
Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
Nephrogenic anaemia (anaemia due to kidney disease)
Renal failure (kidney dysfunction)
Renal hypertension (high blood pressure caused by the kidneys hormonal response)

40-49:

Chronic kidney disease

50-59:

Cystitis (inflammation of the wall of the bladder)
Death
Decreased interest
Dehydration (dryness resulting from the removal of water)
Diarrhoea
Dizziness
Drug ineffective
Dyspnoea (difficult or laboured respiration)
Fatigue (feeling of tiredness)
Gastrointestinal haemorrhage (bleeding gastrointestinal tract)

60+:

Blood creatine phosphokinase increased
Dysphagia (a condition in which swallowing is difficult or painful)
Blood glucose increased
Diaphragmatic disorder
Dyspnoea (difficult or laboured respiration)
Idiopathic thrombocytopenic purpura (bleeding disorder in which the immune system destroys platelets, which are necessary for normal blood clotting)
Pain
Rash
Arthralgia (joint pain)
Diarrhoea

What are the existing conditions these people have? *

High Blood Cholesterol: 12 people, 30.00%
High Blood Pressure: 10 people, 25.00%
Nausea (feeling of having an urge to vomit): 9 people, 22.50%
Type 2 Diabetes: 8 people, 20.00%
Blood Pressure Abnormal: 7 people, 17.50%
Wheezing (a high-pitched whistling sound made while you breath): 6 people, 15.00%
Coronary Heart Disease (narrowing or blockage of the coronary arteries): 6 people, 15.00%
Oedema Peripheral (superficial swelling): 6 people, 15.00%
Neoplasm Malignant (cancer tumour): 6 people, 15.00%
Nausea And Vomiting: 6 people, 15.00%

* Approximation only. Some reports may have incomplete information.

Do you take Metrogel and Lantus?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously